Skip to content


About Us

Board of Directors

Ittai Harel, General Partner, Pitango Venture Capital

Mr. Harel is a veteran of the life sciences field. He has over twenty years of industry experience directing a broad range of responsibilities, from product development and marketing to executive management, in areas such as pharmaceuticals, drug delivery, medical devices, and diagnostics. Before joining Pitango, Mr. Harel headed up corporate development at Nektar Therapeutics (NASDAQ: NKTR) where he was responsible for strategic planning, in-licensing, and mergers and acquisitions. Prior to his work with Nektar, Mr. Harel served as executive vice president at IDGene Pharmaceuticals. During the previous eight years, Mr. Harel held various management positions in Israel and in the U.S. with IDEXX Laboratories (NASDAQ: IDXX).

Mr. Harel currently serves on the board of directors of Inotek Pharmaceuticals, LifeBond, EarlySense, Valeritas, and Vertos Medical, and serves as chairman of the board at LifeBond and EarlySense.

Mr. Harel holds a BS in Chemical Engineering and Biotechnology from Ben Gurion University and an MBA from the MIT Sloan School of Management.

Hugo Harrod, Partner, MVM Life Science Partners LLP

Mr. Harrod is a partner at healthcare investment firm MVM Life Science Partners LLP, which he joined in 2005, and has managed investments from both the London and Boston offices. He has been involved in a wide range of drug and device companies. He led diligence into BioVex (acquired by Amgen), served on the board of Horizon Discovery Plc (floated on the London Stock Exchange) and is currently a director of Accuvein, Inc and eZono AG.

Prior to joining MVM, Mr. Harrod received a financial training at KPMG and qualified with a Masters in Biochemistry from the University of Oxford.

Daniel Pelak, Senior Advisor, Welsh, Carson, Anderson & Stowe

Mr. Pelak has served as a Vertos Medical director since 2008. He is a senior advisor with Welsh, Carson, Anderson & Stowe (WCAS), focusing on investments in the healthcare industry. Prior to joining WCAS, Mr. Pelak was the chief executive officer at InnerPulse, a privately held, early-stage cardiac medical device company. Prior to joining InnerPulse, he was the CEO of Closure Medical Corporation, a publically traded biomaterial-based medical adhesive company, until its acquisition by Johnson & Johnson in 2005. Mr. Pelak began his industry career at Medtronic, where he spent over 20 years. His executive assignments at Medtronic included vice president of U.S. Marketing, and worldwide responsibility for three different operating divisions as vice president and general manager.

Mr. Pelak's current or recent board positions are InnerPulse, Inc., and AGA Medical Corp., Affinergy, Inc., Mardil, Inc., Oncoscope, Inc. Mr. Pelak is a graduate of Penn State University with a BS in Biology.

Rob Kuhling, Managing Director, ONSET Ventures

Rob invests both in medical device companies and IT companies, and has particular insight into the complexities of bringing a medical device to market. His past investments include Access Closure, Aneurx, Clarify, Conceptus, Alteon, Packeteer, Embolic Protection, Endotex, Endocardial Solutions, Apama, and several others.

Rob has been with ONSET since 1987, following a career at Sun Microsystems, where he was Director of Marketing and spearheaded the company's expansion into the design automation marketplace. He had previously served as VP and Manager of General Electric-Calma's $100 million electronic design automation business, and was also a team leader for Boston Consulting Group, overseeing the development of a range of corporate business strategies.

Rob received his B.A. from Hamilton College and his MBA from Harvard Business School.

Eric Wichems, President & Chief Executive Officer, Vertos Medical

Mr. Wichems joined Vertos Medical in September 2011 and served as Vice President of Sales and Marketing prior to becoming president, chief executive officer and member of the board of directors. Previously, Mr. Wichems served as director of marketing for medical devices in the plastic surgery market for Allergan Medical. He has over a decade of experience in the healthcare industry through product management, marketing, and strategic planning assignments at Allergan and Johnson & Johnson.

Mr. Wichems earned a bachelor degree in mechanical engineering from the University of Virginia, a master degree in engineering from North Carolina State University, and a MBA from Duke University.